No Data
No Data
ELTP Stock Falls Following Q3 Earnings Decline, Revenue Down Y/Y
Elite Pharmaceuticals Inc (ELTP) Q3 2025 Earnings Call Highlights: Record Revenue Growth Amid ...
ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
Express News | Elite Pharmaceuticals Q3 EPS $(0.01), Sales $14.36M Down From $15.54M YoY
ELITE PHARMACEUTICALS INC | 10-Q: Q3 2025 Earnings Report
ELITE PHARMACEUTICALS INC (ELTP.US) will release its Earnings Reports after market close on February 13.
$ELITE PHARMACEUTICALS INC(ELTP.US)$ will release its Earnings Reports after the market closes on February 13, and investors are encouraged to pay attention. How were the previous performances? $ELITE PHARMACEUTICALS INC(ELTP.US)$ had revenue of 18.8803 million dollars and a net income of -11.0362 million dollars for Q2 2025, with an EPS of -0.01 dollars. For Q3 2024, the revenue was 15.5388 million dollars and the net income was 0.7064 million dollars. The accounting standards used for the above data are US_